Next Live Webinars

Excipient Selection for Enhancing Bioavailability and Stability in Oral and Injectable Drug Formulations

Excipient impurities causing stability failures? Formulation inconsistencies delaying your launch? Visual quality issues impacting patient confidence?

Join the webinar to discover why excipient selection from day one is critical to your formulation success and how advanced purification technologies can eliminate the hidden risks that compromise drug product quality.

Excipient quality extends beyond compendial specifications. Explore smart selection strategies for complex formulations with poorly water-soluble APIs. Prevent impurity-driven interactions that compromise stability and ensure consistent performance through commercial scale. See breakthrough purification technology achieving up to 54% reduction in color formation while maintaining full functionality.

Why Attend?

Start right: Make informed excipient choices early in development
Reduce risk: Prevent stability failures and batch rejections
Accelerate timelines: Avoid costly reformulation and launch delays
Build confidence: Deliver consistent, high-quality products patients trust

Perfect For:

Formulation scientists
QA/Regulatory professionals
R&D managers
CMC specialists
Technical decision-makers in pharma and biopharma development

What you will learn:

How excipient impurities can influence drug product stability, discoloration, and degradation pathways
Practical strategies for selecting excipients in complex formulations, especially for poorly water-soluble APIs
How excipient purity impacts visual consistency, stability, and manufacturability of drug products
How advanced purification technologies can help mitigate formulation risks

Date & Time & Timezone: Apr 22, 2026 04:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna

Speaker:

Dr. Bhushan Thekedar

Head of Global Business Development, Clariant

Dr. Bhushan Thekedar is Head of Global Business Development for Healthcare at Clariant, where he leads global commercial strategy and growth initiatives for pharmaceutical excipients.

With over 15 years of experience in the life sciences industry, he has held technical and commercial leadership roles at Clariant, Merck KGaA, and BASF, focusing on formulation excipients, bioavailability enhancement technologies, and pharmaceutical ingredient solutions.

Dr. Thekedar combines a strong scientific background with global business development expertise and works closely with pharmaceutical companies to support the development of robust and high-performance drug formulations.

For more information & registration here:

REGISTRATION

Great science for the smallest things

MORE INFORMATION & REGISTRATION

Gattefossé Pharmaceuticals gathers with Skyepharma and RCPE to decipher the innovative solutions for streamlining nanopharmaceutical production. During the “Great science for the smallest things” webinar, technical experts will share insights obtained during the NanoFacT consortium, in particularly: